The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 66

More JCP Articles

JCP
Letter to the Editor

February 11, 2020

In this letter to the editor, Drs Grilo and Udo discuss a recent study that examined links between trauma, PTSD, and binge-eating symptoms; their perspective is set in the…
Carlos M. Grilo, Tomoko Udo
JCP
ASCP Corner

February 4, 2020

Read an article summarizing the treatment options for Premenstrual Dysphoric Disorder (PMDD).
Sara V. Carlini, Kristina M. Deligiannidis
JCP
Review Article

February 4, 2020

Ketamine infusion can produce rapid antidepressant effects, but how to maintain these initial treatment gains remains unclear. This article suggests directions for future investigation in light of past attempts…
George I. Papakostas
JCP
Original Research

February 4, 2020

How can you discriminate between behavioral variant frontotemporal dementia and psychiatric disorders with similar behavioral changes, such as apathy, disinhibition, reduced empathy, or compulsions? Which neuropsychological tests are useful?
Jozefien M. Overbeek, Nicole Korten, Flora Gossink, et al
JCP
Clinical and Practical Psychopharmacology

February 4, 2020

In this article, Dr Andrade provides readers with an understanding of how to critically read a recent study of transcranial direct current stimulation for schizophrenia and demonstrates the importance…
Chittaranjan Andrade
JCP
Original Research

February 4, 2020

Persons with mental illness often are excluded from research despite experiencing morbidity and mortality due to the conditions being studied. This report examines the exclusion of suicidal persons from…
Ana S. Iltis, William V. McCall, Riyan Deria
JCP
Publisher’s Note

January 28, 2020

In this publisher’s note, Dr John Shelton reflects on JCP’s progress over the last 10 years.
John S. Shelton
JCP
Letter to the Editor

January 28, 2020

 Rosenblat and McIntyre reply to the letter “Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?” by Swainson and Khullar.
Joshua D. Rosenblat, Roger S. McIntyre
JCP
Academic Highlights

January 28, 2020

Review highlights from 2 experts’ presentations on identifying and treating tardive dyskinesia. Quotes from actual patients illustrate the embarrassment that they feel and show why even mild movements should…
Joseph P. McEvoy, Daniel E. Kremens
JCP
Consensus Statement

January 28, 2020

Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.
Stanley N. Caroff, Leslie Citrome, Jonathan Meyer, et al
JCP
Letter to the Editor

January 28, 2020

In this letter, doctors describe their experiences with use of sublingual ketamine in a clinical setting and possible us of it as a treatment for depression.
Jennifer Swainson, Atul Khullar
JCP
Educational Activity

January 28, 2020

After so many years of having inadequate treatment options, you can finally offer patients with tardive dyskinesia approved medications that reduce symptoms. Follow along as expert Dr Leslie Citrome…
Leslie L. Citrome

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe